Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Anavex Life Sciences Corp. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 145 | 2 | 169 | +26 |
| Shares | 27.0M | 23.9K | 29.6M | +2.62M (+9.7%) |
| Value | $153.2M | $135.8K | $316.5M | +$163.4M (+106.8%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (47)
Institutions that held Anavex Life Sciences Corp. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (21)
Institutions that held Anavex Life Sciences Corp. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| ExodusPoint Capital Management, LP | 127,270 | $723.0K |
| Deerfield Management Company, L.P. (Series C) | 105,484 | $599.1K |
| HRT Financial LP | 92,163 | $523.0K |
| Gsa Capital Partners LLP | 89,299 | $507.0K |
| American Century Companies Inc | 55,866 | $317.3K |
| Acadian Asset Management LLC | 29,616 | $168.0K |
| Wolverine Trading, LLC | 24,565 | $139.5K |
| Balentine LLC | 20,200 | $114.7K |
| Alpine Global Management, LLC | 18,356 | $104.3K |
| Catalyst Funds Management Pty Ltd | 18,000 | $102.2K |
| Erste Asset Management GmbH | 18,000 | $102.2K |
| Marex Group plc | 10,000 | $56.8K |
| Allspring Global Investments Holdings, LLC | 2,152 | $12.2K |
| Thompson Investment Management, Inc. | 2,000 | $11.4K |
| Flaharty Asset Management, LLC | 1,000 | $5.68K |
| Bray Capital Advisors | 950 | $5.40K |
| Jamison Private Wealth Management, Inc. | 700 | $3.98K |
| Steward Partners Investment Advisory, LLC | 250 | $1.42K |
| Colonial Trust Advisors | 200 | $1.14K |
| Capital Performance Advisors LLP | 135 | $767 |
| Focused Wealth Management, Inc | 500 | – |
Not filed for Q4 2024 yet (2)
Institutions that held Anavex Life Sciences Corp. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 12,275 | $69.7K |
| Raymond James & Associates | 11,631 | $66.1K |